GHS pre-conference workshop: Drug-resistant STIs: A Regional Health Security Risk

18 June 2019
Sydney, Australia

As part of the Global Health Security Conference, GARDP is hosting a pre-conference workshop that focuses on the risks of drug-resistant sexually transmitted infections (STIs) such as Neisseria gonorrhoea and Mycoplasma genitalium to Australian and regional health security. An expert panel of clinicians and researchers will discuss the spread of drug-resistant STIs, diagnostic and surveillance tools, treatment regimens and guidelines, as well as the potential of new antibiotics and how to address sustainable access.

Event Agenda

1300 –  Host: Paul Field, The Global Antibiotic R&D Partnership (GARDP) – Welcome/Introductions
1300 –  Dr. Gary Lum, Principal Medical Advisor, Office of Health Protection – TBA
1315 –  Prof. Monica Lahra, WHO Collaborating Centre for STI and AMR – Neisseria gonorrhoea AMR: Local, Regional, Global
1330 –  Prof. David Whiley, University of Queensland – Detection of Gonococcal Resistance
1345 –  Prof. John Kaldor, Kirby Institute, University of New South Wales – Novel strategies for surveillance among populations at higher risk in the region
1400 –  Dr. Cassandra Kelly-Cirino, Director, Emerging Threats, FIND – Rapid diagnostic tests for drug-resistant STIs
1415 –  Dr. Catriona Bradshaw, Melbourne Sexual Health Centre – Mycoplasma genitalium : Global and regional trends in AMR and management
1430 –  Prof. David Lewis, Marie Bashir Institute, University of Sydney – Guidelines and clinical management strategies for NG and MG
1445 –  Dr. Seamus O’Brien, R&D Director, GARDP – GARDP’s STIs Program
1500 –  Tea 
1515-1600 –  PANEL DISCUSSION, Chair: David Paterson, Director, UQ centre for clinical research
1600 – Conclusions

Date: Tuesday, 18 June 2019 

Venue: ABS Case Study Lecture Theatre 2140, Abercrombie Business School, Corner Abercrombie and Codrington Streets, Darlington, Sydney